Juvena Therapeutics
PrivateLast Round
Series B
Jan 12, 2026
Est. Valuation
$111M
Total Funding Raised
$143.66M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Juvena Therapeutics is a biotechnology company that develops AI-enabled regenerative biologics to restore tissue function and treat chronic and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Juvena Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Juvena Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 12, 2026 | ||||
| Series B | Jul 24, 2025 | ||||
| Series A | Nov 8, 2022 | ||||
| Grant | Feb 2, 2022 | ||||
| Grant | Aug 1, 2021 | ||||
Seed | Feb 26, 2018 |
Juvena Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Horizons Ventures | Series B, Series A |
| NIH RADx | Grant |
| Plum Alley Investments | Series A |
| Intersect VC | Series A |
| Intersect Capital | Series A |
| Jefferson Life Sciences | Series B |
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
$34M round completed.
- Aug 12, 2025
Candidate JUV-112 is currently in lead optimization.
Juvena Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Juvena Therapeutics's valuation, stock price, and market status.